23.04.2010 • News

Eastman Revenue Soars, Considers Divestiture of PET Business

Eastman Chemical reported a first-quarter profit that soared as sales jumped in all five of its operating units. For the period, the company said net income was $101 million, or $1.37 per share, compared with $2 million, or 3 cents per share, in the year-ago period.

Analysts expected earnings of $1.15 per share, according to Thomson Reuters I/B/E/S. Revenue at the Kingsport, Tennessee-company rose 38.5% to $1.56 billion. Analysts expected $1.29 billion in revenue. The company had warned in March that a recent shutdown at a Texas plant would cut first-quarter earnings by at least 20 cents per share.

For the second quarter, Eastman expects to earn $1.50 to $1.60 per share. Analysts expect $1.19 per share. For the year, the company expects to earn $5 to $5.25 per share. Analysts expect $4.51 per share. "With volumes recovering and product mix improving, our first-quarter earnings demonstrated the strength of our core businesses," Chief Executive Jim Rogers said in a statement.

Despite the positive financials Eastman announced it will review strategic options, including a possible divestiture, for its PET business in the Performance Polymers segment. The company has retained Bank of America Merrill Lynch as its exclusive financial advisor for the strategic review.

Company

Eastman Chemical Company

200 South Wilcox Drive
37662 Kingsport

Company contact







Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.